Search Medical Condition
Please enter condition
Please choose location from dropdown

Bandung, Indonesia Clinical Trials

A listing of Bandung, Indonesia clinical trials actively recruiting patients volunteers.

RESULTS

Found (9) clinical trials

Two-month Regimens Using Novel Combinations to Augment Treatment Effectiveness for Drug-sensitive Tuberculosis

The current standard management strategy for drug-sensitive pulmonary tuberculosis (TB) is to treat with multiple drugs for 6 months, although patients often fail to adhere to the long treatment, leading to poor clinical outcomes including drug resistance, which is expensive and difficult to treat. The TRUNCATE-TB trial evaluates an alternative ...

Phase

0.0 miles

Learn More »

Ureteral Stenting After Ureteroscopy for Stone Treatment A Global Perspective on Indications and Outcomes

BACKGROUND AND RATIONALE The majority of patients with stones receive an indication for its active removal by ureteroscopy. In the last two decades, endourological treatment techniques have evolved with several technological advances through miniaturisation of ureteroscopes, digital improvements, and optical imaging enhancement techniques leading to a better image quality, and ...

Phase N/A

0.0 miles

Learn More »

Safety and Efficacy of Early Treatment With Deferiprone in Infants and Young Children

This study will give deferiprone to infants and young children with thalassemia who have started receiving regular blood transfusions but whose iron load is not yet at the level where chelation treatment would normally begin. The purpose is to see if doing this will postpone the build-up of iron without ...

Phase

0.0 miles

Learn More »

Safety and Efficacy of SFPP in Knee Osteoarthritis

The objectives of this study are to demonstrate the non-inferiority of esflurbiprofen plaster (SFPP) 40 mg applied for 2 weeks to diclofenac gel, the comparator, in terms of efficacy in patients with knee osteoarthritis (OA) and to examine the safety of SFPP.

Phase

0.0 miles

Learn More »

Indonesia Pravastatin to Prevent Preeclampsia Study

BACKGROUND Preeclampsia is a major cause of maternal and neonatal morbidity worldwide. There is currently no cure for preeclampsia, the only definitive treatment is termination of pregnancy by induction of labour or caesarean section. Statin has been proposed to represent a new approach to improve disease outcome/prevent preeclampsia based on ...

Phase

0.0 miles

Learn More »

Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region

In this study, patients with SLE will be followed for ~ 5 years. Regular recordings of the data needed to score LLDAS (disease activity and treatment domains, see Franklyn L et al, Ann Rheum Dis 2016) will be collected, as well as annual recording of lupus-related damage using the SLICC_ACR ...

Phase N/A

0.0 miles

Learn More »

A Study to Evaluate the Efficacy Safety and Immunogenicity of Leucostim Versus Neupogen in Breast Cancer Patients

TAC regimen (docetaxel, doxorubicin and cyclophosphamide) is recommended for the adjuvant treatment of breast cancer patients. The TAC regimen is known to lead to significant hematological toxicity and induces febrile neutropenia with a rate > 20%. The use of primary G-CSF prophylaxis with the TAC regimen is recommended by guidelines. ...

Phase

0.0 miles

Learn More »

HIV Awal (Early) Testing & Treatment Indonesia Project Intervention Phase

Description of the Each Proposed Interventions After the qualitative research, literature reviews, thorough discussions, and based on practical/ logistic considerations, there are five specific interventions that have been chosen. Each of the intervention will be presented here in the same format, i.e. rationale of the intervention, aims of the intervention, ...

Phase N/A

2.26 miles

Learn More »

HIV Infection and Risk Related Coinfections/Comorbidities in Indonesia

This study will accept participants meeting the eligibility criteria and data will be collected at baseline visit and 6-monthly regular follow up visits for 3 years (at month 6, 12, 18, 24, 30, and 36). The study will allow a 3-month window period for each scheduled regular follow up visit ...

Phase N/A

2.26 miles

Learn More »